50-65岁孤立性主动脉瓣置换:生物瓣与机械瓣的ANDALVALVE研究
该多中心回顾性研究纳入2000-2015年西班牙安达卢西亚7家医院50-65岁因重度主动脉瓣狭窄行首次孤立主动脉瓣置换的1443例患者,比较生物瓣与机械瓣的远期生存和主要并发症。经倾向评分匹配后,15年生存率生物瓣73%对机械瓣76%(HR 0.80,95%CI 0.54-1.20,P=0.159),≥55岁患者两组15年生存率均为74%(HR 0.88,95%CI 0.56-1.34,P=0.527)。机械瓣主要出血更多(P=0.004),生物瓣再手术更频繁(P=0.01)。
要点
- 50-65岁患者生物瓣与机械瓣远期生存无显著差异。
- ≥55岁患者两组15年生存率均为74%,生物瓣是合理选择。
- 机械瓣主要出血更多,生物瓣再手术更频繁。
核心结论
- 50-65岁因重度主动脉瓣狭窄行孤立主动脉瓣置换的患者中,生物瓣与机械瓣的远期生存相当。
- 55岁以上患者两组15年生存率均为74%,生物瓣是合理选择。
- 机械瓣与更多主要出血相关,生物瓣与更多再手术相关。
研究设计与样本
- 多中心观察性回顾性研究,纳入2000-2015年西班牙安达卢西亚7家公立医院50-65岁因重度主动脉瓣狭窄行首次孤立主动脉瓣置换的患者。
- 排除合并手术、再次手术和心内膜炎者,共纳入1443例(生物瓣272例,机械瓣1171例)。
- 采用多因素分析及2:1倾向评分匹配(机械瓣506例,生物瓣257例)。
主要发现
- 生物瓣植入占18.8%(n=272),其中女性35%,平均EuroSCORE-I为3%。
- 匹配样本平均随访8.1±4.9年:机械瓣组8.8±4.9年,生物瓣组7.1±4.5年(P=0.001)。
- 匹配样本15年生存率生物瓣73%对机械瓣76%(HR 0.80,95%CI 0.54-1.20;P=0.159)。
- ≥55岁患者两组15年生存率均为74%(HR 0.88,95%CI 0.56-1.34;P=0.527)。
- 机械瓣组主要出血率更高(P=0.004),生物瓣组再手术更频繁(P=0.01)。
关键数值与推荐
- 生物瓣植入占18.8%(n=272)。
- 匹配样本15年生存率:生物瓣73%,机械瓣76%(HR 0.80,95%CI 0.54-1.20;P=0.159)。
- ≥55岁患者15年生存率两组均为74%(HR 0.88,95%CI 0.56-1.34;P=0.527)。
- 主要出血机械瓣组更高(P=0.004),再手术生物瓣组更频繁(P=0.01)。
临床怎么用
- 50-65岁重度主动脉瓣狭窄行孤立主动脉瓣置换时,生物瓣与机械瓣远期生存相当。
- 55岁以上患者可考虑生物瓣,需权衡主要出血与再手术风险。
- 选择瓣膜类型时应个体化评估出血风险与再手术风险。
局限性
- 回顾性观察性设计,可能存在选择偏倚。
- 生物瓣组样本量较小(272例),匹配后生物瓣257例。
- 匹配样本中两组随访时间存在差异(P=0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The decision about whether to use a biological or a mechanical prosthesis for aortic valve replacement remains controversial in patients between 50 and 65 years of age and has yet to be addressed in a Mediterranean population. This research aimed to analyse long-term survival and major morbidity rates (30-day mortality, stroke, any prosthetic reoperation and major bleeding) within this population. METHODS: Our multicentre observational retrospective study included all subjects aged 50-65 years who had a primary isolated aortic valve replacement due to severe aortic stenosis at 7 public hospitals from Andalusia (Spain) between 2000 and 2015. Concomitant surgery, reoperations and endocarditis were the exclusion criteria. A total of 1443 patients were enrolled in the study (272 with biological and 1171 with mechanical valves). Multivariate analyses including a 2:1 propensity score matching (506 mechanical and 257 biological prostheses) were conducted. RESULTS: Bioprostheses were implanted in 18.8% (n = 272): 35% were women; the mean EuroSCORE-I was 3%. The mean follow-up was 8.1 ± 4.9 years in a matched sample: 8.8 ± 4.9 years in those receiving a mechanical vs 7.1 ± 4.5 years in those receiving a biological prosthesis (P = 0.001). In the paired sample, the 15-year survival rate was 73% in those who had a biological vs 76% in those who had a mechanical valve [hazard ratio (HR) 0.80, 95% confidence interval (CI) 0.54-1.20; P = 0.159]. No significant differences were observed in patients ≥55 years old (74% of 15-year survival in both groups: HR 0.88, 95% CI 0.56-1.34; P = 0.527). A higher rate of major bleeding was found in patients with a mechanical prosthesis (P = 0.004), whereas reoperation was more frequent among those with a biological prosthesis (P = 0.01). CONCLUSIONS: Long-term survival was comparable in patients above 55 years of age. Mechanical prostheses were associated with more major bleeding and bioprostheses, with more reoperations. A bioprosthesis in patients above 55 years old is a reasonable choice. CLINICAL TRIAL REGISTRATION NUMBER: NCT03239509.
引用
- Rodríguez-Caulo EA, Macías D, Adsuar A, et al. Biological or mechanical prostheses for isolated aortic valve replacement in patients aged 50-65 years: the ANDALVALVE study. Eur J Cardiothorac Surg. 2019. PMID: 30608571. doi:10.1093/ejcts/ezy459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。